搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Streptococcus pneumoniae 50S ribosomal protein L33 1 (rpmG1) CSB-YP813330SMP
CSB-EP813330SMP
CSB-BP813330SMP
CSB-MP813330SMP
CSB-EP813330SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L11 (rplK) CSB-YP813331SMP
CSB-EP813331SMP
CSB-BP813331SMP
CSB-MP813331SMP
CSB-EP813331SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L6 (rplF) CSB-YP813332SMP
CSB-EP813332SMP
CSB-BP813332SMP
CSB-MP813332SMP
CSB-EP813332SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Glycogen synthase (glgA) CSB-YP813333FMR
CSB-EP813333FMR
CSB-BP813333FMR
CSB-MP813333FMR
CSB-EP813333FMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Glycine--tRNA ligase alpha subunit (glyQ) CSB-YP813334FMR
CSB-EP813334FMR
CSB-BP813334FMR
CSB-MP813334FMR
CSB-EP813334FMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Trigger factor (tig) CSB-YP813335FMR
CSB-EP813335FMR
CSB-BP813335FMR
CSB-MP813335FMR
CSB-EP813335FMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant tRNA pseudouridine synthase A (truA) CSB-YP813336SMI
CSB-EP813336SMI
CSB-BP813336SMI
CSB-MP813336SMI
CSB-EP813336SMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase (murG) CSB-YP813337SGA
CSB-EP813337SGA
CSB-BP813337SGA
CSB-MP813337SGA
CSB-EP813337SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis tRNA modification GTPase MnmE (mnmE) CSB-YP813338SGA
CSB-EP813338SGA
CSB-BP813338SGA
CSB-MP813338SGA
CSB-EP813338SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis UvrABC system protein C (uvrC), partial CSB-YP813339OAB
CSB-EP813339OAB
CSB-BP813339OAB
CSB-MP813339OAB
CSB-EP813339OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis DNA repair protein recO (recO) CSB-YP813340OAB
CSB-EP813340OAB
CSB-BP813340OAB
CSB-MP813340OAB
CSB-EP813340OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Thiol-disulfide oxidoreductase resA (resA), partial CSB-YP813341OAB1
CSB-EP813341OAB1
CSB-BP813341OAB1
CSB-MP813341OAB1
CSB-EP813341OAB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP813342OAB
CSB-EP813342OAB
CSB-BP813342OAB
CSB-MP813342OAB
CSB-EP813342OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis GMP synthase [glutamine-hydrolyzing] (guaA), partial CSB-YP813343OAB
CSB-EP813343OAB
CSB-BP813343OAB
CSB-MP813343OAB
CSB-EP813343OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma penetrans tRNA dimethylallyltransferase (miaA) CSB-YP813344MLU
CSB-EP813344MLU
CSB-BP813344MLU
CSB-MP813344MLU
CSB-EP813344MLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai Queuine tRNA-ribosyltransferase (tgt) CSB-YP813345LOS
CSB-EP813345LOS
CSB-BP813345LOS
CSB-MP813345LOS
CSB-EP813345LOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant HTH-type transcriptional activator rhaS (rhaS) CSB-YP813346EGX
CSB-EP813346EGX
CSB-BP813346EGX
CSB-MP813346EGX
CSB-EP813346EGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella suis biovar 1 Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] (glmS), partial CSB-YP813347BMQ
CSB-EP813347BMQ
CSB-BP813347BMQ
CSB-MP813347BMQ
CSB-EP813347BMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum 10 kDa chaperonin (groS) CSB-YP813348BGP
CSB-EP813348BGP
CSB-BP813348BGP
CSB-MP813348BGP
CSB-EP813348BGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae UPF0371 protein spr0309 (spr0309) CSB-YP813349SMP
CSB-EP813349SMP
CSB-BP813349SMP
CSB-MP813349SMP
CSB-EP813349SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>